Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophils and cysteinyl leukotrienes.

Christianne Bandeira-Melo1, Peter F Weller

  • 1Department of Medicine, Charles A Dana Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. cbmelo@gene.dbbm.fiocruz.br

Prostaglandins, Leukotrienes, and Essential Fatty Acids
|August 5, 2003
PubMed
Summary

Eosinophils produce cysteinyl leukotrienes (LTC4/D4/E4), key mediators in allergic inflammation like asthma. This review details eosinophil LTC4 synthesis, receptor interactions, and novel intracellular signaling pathways.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sombrero vesicles: from overlooked structures to primary mediators of eosinophil secretion.

Journal of leukocyte biology·2026
Same author

IL-33 Elicits LTC<sub>4</sub> Synthesis in Allergic Inflammation via ST2-Mediated Activation of Eosinophils.

European journal of immunology·2026
Same author

Long-Term Safety and Efficacy of Mepolizumab in Eosinophilic Granulomatosis With Polyangiitis.

Arthritis & rheumatology (Hoboken, N.J.)·2025
Same author

Humanized FcεRI Expressed on Mouse Eosinophils Mediates IgE-Facilitated Eosinophil Antigen Presentation.

Cells·2025
Same author

Endogenous PGD2 acting on DP2 receptor counter regulates Schistosoma mansoni infection-driven hepatic granulomatous fibrosis.

PLoS pathogens·2024
Same author

Eosinophil extracellular vesicles and DNA traps in allergic inflammation.

Frontiers in allergy·2024

Area of Science:

  • Immunology
  • Allergy and Inflammation Research
  • Cellular Biology

Background:

  • Eosinophils are primary producers of cysteinyl leukotrienes (LTC4/D4/E4), potent lipid mediators implicated in asthma and allergic diseases.
  • Understanding eosinophil eicosanoid synthesis is crucial for developing targeted anti-inflammatory therapies.
  • Cysteinyl leukotrienes mediate their effects through specific G protein-coupled receptors.

Purpose of the Study:

  • To review the intricate mechanisms of eosinophil LTC4 synthesis.
  • To explore the role of intracellular domains in regulating eicosanoid formation and function.
  • To present recent findings on cysteinyl leukotriene receptor (CysLT) activation on eosinophils.

Main Methods:

  • Literature review focusing on eosinophil biology and lipid mediator synthesis.

Related Experiment Videos

  • Analysis of intracellular signaling pathways governing eicosanoid production.
  • Synthesis of recent data on CysLT receptor expression and function in eosinophils.

    • Main Results:

    • Eosinophils possess complex intracellular machinery for LTC4 synthesis and regulation.
    • Eosinophils express both CysLT1 and CysLT2 receptors, mediating paracrine and autocrine signaling.
    • Emerging evidence suggests novel intracellular (intracrine) effects of LTC4 via a potential third CysLT receptor.

    Conclusions:

    • Eosinophil LTC4 synthesis is a tightly regulated process involving specific intracellular domains.
    • Paracrine, autocrine, and intracrine signaling pathways involving CysLT receptors contribute to eosinophil-mediated inflammation.
    • Further research into these pathways may reveal new therapeutic targets for allergic diseases.